The Health and Human Services Secretary directed the FDA to consider eliminating a pathway that allowed companies to "self-affirm" whether their ingredients are safe for consumption.

On Thursday (March 13), shares of and Pharmaceuticals Ltd ended at ₹1,518.00, up by ₹13.30, or 0.88%, on the BSE.

Q4 2024 Earnings Call Transcript March 13, 2025 Cellectar Biosciences, Inc. beats earnings expectations. Reported EPS is ...

Q4 2024 Earnings Call Transcript March 13, 2025 Operator: Hello, and welcome to Nyxoah Fourth Quarter 2024 Earnings ...

Donald Trump's health secretary vowed to “Make America Healthy Again" but has delivered an inconsistent message that has ...

KRRO-110 is the first RNA editing development candidate from Korro's proprietary OPERA TM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of the ...

The U.S. Food and Drug Administration issued a recall notice Tuesday for several lots of six products, including Walgreens ...

For decades, the U.S. Food and Drug Administration's GRAS rule has allowed untested additives into the food supply. Can RFK ...

Robert F Kennedy Jr, Secretary of the US Health and Human Services, has begun targetting ultra-processed foods. Kennedy Jr has claimed that these foods are the cause of several chronic diseases that ...

Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...